We are excited to share Arnauld Sergé‘s participation in European Thymus in Porto, 27-31 May 2024
Arnauld presented a poster titled “Dynamics and Blockade of RANK/RANKL Interactions Between Leukemic and Thymic Epithelial Cells,” with contributions from Loriane Maillot, Martine Biarnes Pelicot, and Magali Irla from CIML.
T-cell acute lymphoblastic leukemias (T-ALL) are aggressive hematological cancers arising in the thymus from the malignant transformation of thymocytes. RANK and its ligand RANKL play a key role in thymic crosstalk. RANKL promotes thymic epithelial cell differentiation, sustaining the generation of a self-tolerant T-cell repertoire. The RANK/RANKL axis is a therapeutic target in oncology. However, its role in T-ALL remains unclear. RANKL is overexpressed during leukemogenesis. (i) we evaluate the dynamics of RANK/RANKL interactions, measured by single-molecule tracking. We evaluate the effects of an anti-RANKL antibody, a decoy receptor and the soluble form of RANKL. (ii) we assessthe therapeutic potential of an anti-RANKL antibody in T-ALL dissemination. Our aim is to shed light on the role of the RANK/RANKL axis in the emergence and dissemination of T-ALL.













You must be logged in to post a comment.